GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (FRA:3AC) » Definitions » Other Gross PPE

Actinogen Medical (FRA:3AC) Other Gross PPE : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Other Gross PPE?

Actinogen Medical's Other Gross PPE for the quarter that ended in Dec. 2023 was €0.00 Mil.

Actinogen Medical's quarterly Other Gross PPE increased from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.05 Mil) but then declined from Jun. 2023 (€0.05 Mil) to Dec. 2023 (€0.00 Mil).

Actinogen Medical's annual Other Gross PPE declined from Jun. 2021 (€0.15 Mil) to Jun. 2022 (€0.10 Mil) and declined from Jun. 2022 (€0.10 Mil) to Jun. 2023 (€0.05 Mil).


Actinogen Medical Other Gross PPE Historical Data

The historical data trend for Actinogen Medical's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Other Gross PPE Chart

Actinogen Medical Annual Data
Trend Jun13 Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.23 0.15 0.10 0.05

Actinogen Medical Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.10 - 0.05 -

Actinogen Medical Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Actinogen Medical (FRA:3AC) Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.

Actinogen Medical (FRA:3AC) Headlines

No Headlines